4.8 Article

Role of the histone domain in the autoinhibition and activation of the Ras activator Son of Sevenless

出版社

NATL ACAD SCIENCES
DOI: 10.1073/pnas.0913915107

关键词

crystal structure; membrane-binding; PIP2-dependent; SOS

资金

  1. NIGMS NIH HHS [R01 GM078266] Funding Source: Medline

向作者/读者索取更多资源

Membrane-bound Ras is activated by translocation of the Son of Sevenless (SOS) protein to the plasma membrane. SOS is inactive unless Ras is bound to an allosteric site on SOS, and the Dbl homology (DH) and Pleckstrin homology (PH) domains of SOS (the DH-PH unit) block allosteric Ras binding. We showed previously that the activity of SOS at the membrane increases with the density of PIP2 and the local concentration of Ras-GTP, which synergize to release the DH-PH unit. Here we present a new crystal structure of SOS that contains the N-terminal histone domain in addition to the DH-PH unit and the catalytic unit (SOSHDFC, residues 1-1049). The structure reveals that the histone domain plays a dual role in occluding the allosteric site and in stabilizing the autoinhibitory conformation of the DH-PH unit. Additional insight is provided by kinetic analysis of the activation of membrane-bound Ras by mutant forms of SOS that contain mutations in the histone and the PH domains (E108K, C441Y, and E433K) that are associated with Noonan syndrome, a disease caused by hyperactive Ras signaling. Our results indicate that the histone domain and the DH-PH unit are conformationally coupled, and that the simultaneous engagement of the membrane by a PH domain PIP2-binding interaction and electrostatic interactions between a conserved positively charged patch on the histone domain and the negatively charged membrane coincides with a productive reorientation of SOS at the membrane and increased accessibility of both Ras binding sites on SOS.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Biochemistry & Molecular Biology

The F-Box Domain-Dependent Activity of EMI1 Regulates PARPi Sensitivity in Triple-Negative Breast Cancers

Antonio Marzio, Joseph Puccini, Youngho Kwon, Natalia K. Maverakis, Arnaldo Arbini, Patrick Sung, Dafna Bar-Sagi, Michele Pagano

MOLECULAR CELL (2019)

Article Biochemistry & Molecular Biology

BTK signaling drives CD1dhiCD5+ regulatory B-cell differentiation to promote pancreatic carcinogenesis

Shipra Das, Dafna Bar-Sagi

ONCOGENE (2019)

Article Cell Biology

ATDC is required for the initiation of KRAS-induced pancreatic tumorigenesis

Lidong Wang, Huibin Yang, Andrea Zamperone, Daniel Diolaiti, Phillip L. Palmbos, Ethan Abel, Vinee Purohit, Igor Dolgalev, Andrew D. Rhim, Mats Ljungman, Christina H. Hadju, Christopher J. Halbrook, Dafna Bar-Sagi, Marina Pasca di Magliano, Howard C. Crawford, Diane M. Simeonel

GENES & DEVELOPMENT (2019)

Article Oncology

Tumor Cell-Derived IL1β Promotes Desmoplasia and Immune Suppression in Pancreatic Cancer

Shipra Das, Beny Shapiro, Emily A. Vucic, Sandra Vogt, Dafna Bar-Sagi

CANCER RESEARCH (2020)

Article Multidisciplinary Sciences

Plasma membrane V-ATPase controls oncogenic RAS-induced macropinocytosis

Craig Ramirez, Andrew D. Hauser, Emily A. Vucic, Dafna Bar-Sagi

NATURE (2019)

Article Biochemistry & Molecular Biology

Covalent Targeting of Ras G12C by Rationally Designed Peptidomimetics

Daniel Y. Yoo, Andrew D. Hauser, Stephen T. Joy, Dafna Bar-Sagi, Paramjit S. Arora

ACS CHEMICAL BIOLOGY (2020)

Article Oncology

Selective Alanine Transporter Utilization Creates a Targetable Metabolic niche in Pancreatic Cancer

Seth J. Parker, Caroline R. Amendola, Kate E. R. Hollinshead, Qijia Yu, Keisuke Yamamoto, Joel Encarnacion-Rosado, Rebecca E. Rose, Madeleine M. LaRue, Albert S. W. Sohn, Doug E. Biancur, Joao A. Paulo, Steven P. Gygi, Drew R. Jones, Huamin Wang, Mark R. Philips, Dafna Bar-Sagi, Joseph D. Mancias, Alec C. Kimmelman

CANCER DISCOVERY (2020)

Article Chemistry, Multidisciplinary

Macropinocytosis as a Key Determinant of Peptidomimetic Uptake in Cancer Cells

Daniel Y. Yoo, Stephanie A. Barros, Gordon C. Brown, Christian Rabot, Dafna Bar-Sagi, Paramjit S. Arora

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2020)

Editorial Material Oncology

A novel target for combination immunotherapy in pancreatic cancer: IL-1β mediates immunosuppression in the tumour microenvironment

Rafael Winograd, Diane M. Simeone, Dafna Bar-Sagi

Summary: Immune checkpoint blockade has shown efficacy in multiple cancers, but further improvements are needed to increase response rates and achieve clinical efficacy in cold tumors. Mechanistic studies of tumor-specific immunosuppressive pathways can uncover biological barriers to immunotherapy and offer new therapeutic insights.

BRITISH JOURNAL OF CANCER (2021)

Article Cell Biology

Gain-of-function p53R172H mutation drives accumulation of neutrophils in pancreatic tumors, promoting resistance to immunotherapy

Despina Siolas, Emily Vucic, Emma Kurz, Cristina Hajdu, Dafna Bar-Sagi

Summary: Tumor genotype can influence the immune microenvironment in pancreatic cancer, leading to changes in immune cell populations and affecting treatment outcomes. Depletion of neutrophils in CRISPR Kras(G12D/+);Trp53(R172H/+) tumors can enhance the efficacy of CD40 immunotherapy and chemotherapy.

CELL REPORTS (2021)

Article Biochemistry & Molecular Biology

EMSY inhibits homologous recombination repair and the interferon response, promoting lung cancer immune evasion

Antonio Marzio, Emma Kurz, Jennifer M. Sahni, Giuseppe Di Feo, Joseph Puccini, Shaowen Jiang, Carolina Alcantara Hirsch, Arnaldo A. Arbini, Warren L. Wu, Harvey Pass, Dafna Bar-Sagi, Thales Papagiannakopoulos, Michele Pagano

Summary: NSCLCs with KEAP1 mutations show resistance to immunotherapy due to EMSY accumulation suppressing immune response. KEAP1 loss results in stabilized EMSY, causing HRR defects and sensitivity to PARP inhibitors. The accumulation of EMSY impairs immune signaling and promotes immune evasion. Activation of the type I interferon response using a STING agonist inhibits KEAP1-mutant tumor growth, suggesting a potential therapeutic strategy for NSCLC patients with KEAP1 alterations.
Article Oncology

Exercise-induced engagement of the IL-15/1L-15Rα axis promotes anti-tumor immunity in pancreatic cancer

Emma Kurz, Carolina Alcantara Hirsch, Tanner Dalton, Sorin Alberto Shadaloey, Alireza Khodadadi-Jamayran, George Miller, Sumedha Pareek, Hajar Rajaei, Chirayu Mohindroo, Seyda Baydogan, An Ngo-Huang, Nathan Parker, Matthew H. G. Katz, Maria Petzel, Emily Vucic, Florencia McAllister, Keri Schadler, Rafael Winograd, Dafna Bar-Sagi

Summary: Aerobic exercise reduces the growth of pancreatic ductal adenocarcinoma (PDA) by modulating the immune system. It promotes the accumulation of tumor-infiltrating immune cells and enhances the tumor-protective effects. In clinical samples, an increase of anti-tumor immune cells is observed. Targeting the IL-15/IL-15R alpha pathway shows promising results in treatment.

CANCER CELL (2022)

Article Multidisciplinary Sciences

Metabolic reprogramming of tumor-associated macrophages by collagen turnover promotes fibrosis in pancreatic cancer

Madeleine M. LaRue, Seth Parker, Joseph Puccini, Michael Cammer, Alec C. Kimmelman, Dafna Bar-Sagi

Summary: Tumor-associated macrophages play a role in remodeling the extracellular matrix, which affects the growth and development of tumors.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2022)

Article Endocrinology & Metabolism

Adaptive stimulation of macropinocytosis overcomes aspartate limitation in cancer cells under hypoxia

Javier Garcia-Bermudez, Michael A. Badgley, Sheela Prasad, Lou Baudrier, Yuyang Liu, Konnor La, Mariluz Soula, Robert T. Williams, Norihiro Yamaguchi, Rosa F. Hwang, Laura J. Taylor, Elisa de Stanchina, Bety Rostandy, Hanan Alwaseem, Henrik Molina, Dafna Bar-Sagi, Kivanc Birsoy

Summary: This study reveals that pancreatic tumor cells overcome aspartate limitation in hypoxia by upregulating macropinocytosis.

NATURE METABOLISM (2022)

Review Oncology

Exploiting cancer's drinking problem: regulation and therapeutic potential of macropinocytosis

Joseph Puccini, Michael Alexander Badgley, Dafna Bar-Sagi

Summary: This review discusses the recent advances in understanding macropinocytosis, including its regulatory pathways, its contribution to the metabolic fitness of cancer cells, and its therapeutic potential.

TRENDS IN CANCER (2022)

暂无数据